Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva
NCT ID: NCT06085547
Last Updated: 2025-01-17
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
264 participants
INTERVENTIONAL
2023-05-04
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mobile Health-based Motivational Interviewing to Promote COVID-19 Vaccination
NCT05977192
Exploring Vaccine Confidence and Uptake of Potential COVID-19 Vaccines
NCT04731870
Equitable Access to COVID-19 Vaccines
NCT04952376
Feasibility of Rapid COVID-19 Testing in Disadvantaged Populations
NCT04558307
COVID-19 Testing and Vaccine Literacy for Women With Criminal Legal System Involvement
NCT05582746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
White Rural: General
White rural participants receive "general consumption" video information about SARS-CoV-2 antibody testing.
General SARS-CoV-2 Communication
SARS-CoV-2 video tutorial is for general consumption and does not include rural-targeted information
White Rural: Rural-Targeted
White rural participants receive rural-targeted video information about SARS-CoV-2 antibody testing.
Rural-Targeted SARS-CoV-2 Communication
SARS-CoV-2 video tutorial includes a two and a half minute video based messaging adjunct meant to enact a rural-targeted framing of health information presented to White rural individuals.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General SARS-CoV-2 Communication
SARS-CoV-2 video tutorial is for general consumption and does not include rural-targeted information
Rural-Targeted SARS-CoV-2 Communication
SARS-CoV-2 video tutorial includes a two and a half minute video based messaging adjunct meant to enact a rural-targeted framing of health information presented to White rural individuals.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
National Cancer Institute (NCI)
NIH
Michigan State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Todd Lucas
C.S. Mott Endowed Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Flint Journal Building
Flint, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00005016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.